Shilajit vs Ashwagandha: Which Is Better for Testosterone?
Should I take shilajit or ashwagandha?
Shilajit scores 7.4 and ashwagandha 6.8, but that gap is the least useful number here. These two do different jobs. Shilajit is the mineral and androgen play: male fertility 7.5, hormonal 7.5, energy 6.5. Ashwagandha is the cortisol play: stress 7.5, anxiety 7.5, sleep 6.5. Buy the one matching your complaint. If that complaint is stress, the lower-scoring herb wins.
- Shilajit 7.4, ashwagandha 6.8. The 0.6 gap comes from downside, not from effect: ashwagandha carries documented liver-injury cases and thyroid stimulation that shilajit does not.
- Their mechanisms barely touch. Shilajit moves trace minerals and runs antioxidant and mild gonadotropic signaling. Ashwagandha damps the HPA axis and lowers cortisol through GABA-A. You can run both without redundancy.
- Ashwagandha wins anxiety 7.5 to 2.5 and sleep quality 6.5 to 2.0 despite the lower overall score. Shilajit does almost nothing for either.
- Shilajit wins male fertility 7.5 to 6.0 and energy 6.5 to 3.5, and it is the only one of the two with a 48-week bone-density RCT (Pingali 2022).
- Ashwagandha is faster and cheaper: first change in about a week at $15 to $30 a month, against four weeks at $25 to $50 for shilajit. Both are retail estimates, not measured prices.
- Ashwagandha's evidence base is far deeper. Six systematic reviews and meta-analyses against shilajit's small, mostly ingredient-funded RCTs.
- Only shilajit needs lot-specific heavy-metal testing before you swallow it. That is not optional, it is the defining risk of the category.
At a Glance
Shilajit
- Efficacy 3.8
- Breadth 4.7
- Evidence 3.8
- Speed 2.5
- Durability 2.5
- Bioindividuality 3.8
- Safety Risk 1.9
- Side Effects 1.8
- Cost 2.5
- Effort 1.5
- Opportunity Cost 1.5
- Dependency 1.2
- Reversibility 1.2
- Hormonal
- Fertility Male
- Bone Joint
- Energy
Purified fulvic and humic acid resin. BioHarmony 7.4, strong recommend.
Ashwagandha
- Efficacy 3.8
- Breadth 4.5
- Evidence 4.0
- Speed 3.0
- Durability 2.5
- Bioindividuality 3.5
- Safety Risk 2.5
- Side Effects 2.3
- Cost 1.5
- Effort 1.0
- Opportunity Cost 2.0
- Dependency 1.5
- Reversibility 1.5
- Stress Resilience
- Anxiety
- Sleep Quality
- Hormonal
Withanolide-standardized root extract. BioHarmony 6.8, worth trying.
Head-to-Head Verdict
| Use Case | Winner | Rationale |
|---|---|---|
| Hormonal | Shilajit | Shilajit 7.5 against ashwagandha 6.5. Pandit 2016 is a randomized trial of 500 mg/day for 90 days reporting increased total testosterone, free testosterone and DHEAS in healthy men. Ashwagandha's hormonal evidence (Lopresti 2019) is a crossover study in aging overweight males whose numeric wording our own report tempered on audit. Both are small, and shilajit's is the more direct test. |
| Fertility Male | Shilajit | Shilajit 7.5 against ashwagandha 6.0, and this is the one row where a clinical population was actually studied. Biswas 2010 tested processed shilajit in oligospermic men and supports improved sperm parameters with testosterone and FSH moving in the expected direction. Neither product is recommended by the AUA/ASRM male infertility guideline, which our report cites to make that point. |
| Energy | Shilajit | Shilajit 6.5 against ashwagandha 3.5, the widest gap on shilajit's side. This is a mechanism story rather than a trial story: dibenzo-alpha-pyrones shuttle electrons in the mitochondrion, which is also why shilajit's mitochondrial subrating is 5.0 against ashwagandha's 2.5. Keller 2019 showed better preservation of fatigue-related strength, which is the closest human proxy we hold. |
| Stress Resilience | Ashwagandha | Ashwagandha 7.5 against shilajit 4.0, and the evidence gap is bigger than the score gap. Arumugam 2024 pooled 9 RCTs and 558 people and found lower perceived stress, lower anxiety and lower serum cortisol against placebo. Shilajit has no controlled stress trial at all. Its 4.0 is adaptogenic tradition, not measured cortisol. |
| Anxiety | Ashwagandha | Ashwagandha 7.5 against shilajit 2.5. Fatima 2024 pooled 5 RCTs and 254 people and found reduced HAM-A anxiety scores, with high heterogeneity that keeps this at moderate confidence rather than high. Shilajit scores 2.5 because nothing has tested it here. If anxiety is the reason you are shopping, the 6.8-scoring herb beats the 7.4-scoring one outright. |
| Sleep Quality | Ashwagandha | Ashwagandha 6.5 against shilajit 2.0, and sleep architecture runs 4.5 against 1.0. Langade 2019 measured objective and subjective sleep in insomnia and anxiety, and Cheah 2021 pooled the sleep literature into a small but real overall effect that gets stronger in insomnia populations and at higher doses. Shilajit does not belong in a sleep stack. |
| Bone Joint | Shilajit | Shilajit 6.5 against ashwagandha 4.0, on the single longest trial either side holds. Pingali and Nutalapati 2022 ran 60 osteopenic postmenopausal women for 48 weeks and reported dose-dependent preservation of lumbar-spine and femoral-neck bone mineral density. Neltner 2022 adds a collagen synthesis marker rising at 500 and 1000 mg/day. Ashwagandha has nothing comparable on bone. |
| Mood | Ashwagandha | Ashwagandha 6.0 against shilajit 3.0. Alsanie 2026 is a dose-response meta-analysis across 22 RCTs and 1391 people showing improvement in stress, anxiety and depression, with the authors' own low-certainty caveat carried forward here. Note that shilajit's report scores depression separately and ashwagandha's does not, so mood is the row that compares cleanly. |
| Strength Power | Tie | Call this even, against the subratings. Shilajit scores 6.0 and ashwagandha 5.0, but ashwagandha holds the better evidence: Wankhede 2015 is a resistance-training RCT on strength and recovery, and Bonilla 2021 is a Bayesian meta-analysis of physical performance. Shilajit holds one trial (Keller 2019) in 63 men, and it measured strength preserved under fatigue rather than strength gained. |
| Libido | Tie | Both 5.5, and neither earns more. Shilajit's libido case rides on the testosterone finding rather than a libido endpoint. Ashwagandha's rides on the sexual-function signals in Ferreira 2025, an overview of 11 systematic reviews that explicitly cautions on evidence limits. Mid-scores on both sides, so pick on the row above this one instead. |
| Muscle Growth | Tie | Ashwagandha 5.0 against shilajit 4.5, inside the noise. Neither is a hypertrophy agent. Wankhede 2015 gives ashwagandha the only training-context RCT of the two, so if you are forced to choose it leans that way, but a 0.5 subrating gap is not a reason to buy anything. |
Cost Comparison
| Intervention | Monthly Cost | Notes |
|---|---|---|
| Shilajit | $25 to $50 | ESTIMATE, priced 2026-09-08, ordinary supplement retail. The report prices purified shilajit capsules at $25 to $50 a month for the 300 to 500 mg/day range this protocol uses. Resin runs $50 to $100 per jar lasting four to eight weeks. Cheap bulk resin is the trap here, not the bargain: it is the form most associated with heavy-metal contamination. |
| Ashwagandha | $15 to $30 | ESTIMATE, priced 2026-09-07, ordinary supplement retail. KSM-66 at 600 mg/day runs $15 to $30 a month for third-party-tested extract. Generic root powder is $5 to $15 but carries adulteration risk, and the standardized extracts are what every trial cited on this page actually used. |
| The difference | About $15 a month, and ashwagandha cycles off | Ashwagandha is roughly $15 a month cheaper at the doses that were studied, which is real but small enough that it should not decide anything on its own.The bigger cost difference is duration. Ashwagandha's own contraindication list names continuous use beyond 8 to 12 weeks without a break, so the annual spend is a fraction of twelve months. Shilajit is priced as a continuous supplement with a 12-week assessment window and no built-in washout, so its annual figure is the full $300 to $600. |
When to Switch
These two run on different clocks, so do not judge them on the same schedule. Ashwagandha gives a first noticeable change in about a week and reaches full effect at eight, which is also its assessment window. Shilajit takes about four weeks for a first signal and twelve for full effect. If you started shilajit three weeks ago and felt nothing, that is the expected result, not a failure.
Switch from shilajit to ashwagandha when the thing you actually wanted was calm rather than drive. The tell is that energy improved on paper but sleep, mood or stress did not: shilajit scores 2.0 on sleep quality and 2.5 on anxiety, so there was never a mechanism there to wait for.
Switch the other way, from ashwagandha to shilajit, when the stress problem resolved but low drive, fatigue or a fertility workup is what remains, or when you hit ashwagandha's 8-to-12-week continuous-use ceiling and want something you can take through the break.
Running both is defensible, which is unusual in a head-to-head. HPA-axis damping and trace-mineral transport are complementary rather than redundant, and neither contraindication list names the other.
Two cautions if you do: ashwagandha stimulates thyroid output and shilajit does not counter it, and stacking two supplements at once means a null result tells you nothing about which one failed. Start them four weeks apart.
Who Should Pick What?
Man in his 30s or 40s with low drive, flat energy and a fertility question
Shilajit
Male fertility 7.5 against 6.0, hormonal 7.5 against 6.5, energy 6.5 against 3.5. Pandit 2016 and Biswas 2010 are the two trials that speak to this profile directly. Get a semen analysis first so you have something to compare against at twelve weeks, and buy only lot-tested purified product.
Anyone whose main complaint is anxiety or a racing mind at night
Ashwagandha
Anxiety 7.5 against 2.5, sleep quality 6.5 against 2.0. This is the row where the lower overall score wins outright, because shilajit has no anxiety mechanism to offer. Fatima 2024 and Langade 2019 both measured this population. Take it at 300 mg twice daily and reassess at eight weeks.
Chronically stressed high performer with normal labs
Ashwagandha
Stress resilience 7.5 against 4.0, and Arumugam 2024 pooled 9 RCTs showing cortisol itself came down, not just how people rated their stress. Plan the break in advance: continuous use beyond 8 to 12 weeks without one is on the contraindication list.
Postmenopausal woman worried about bone density
Shilajit
Bone and joint 6.5 against 4.0, on the strength of a 48-week RCT in 60 osteopenic postmenopausal women (Pingali 2022) with dose-dependent preservation of lumbar-spine and femoral-neck BMD. This is the longest trial on either side of this comparison. It supplements a DEXA-guided plan, it does not replace one.
Anyone with a thyroid condition or on levothyroxine
Shilajit
Ashwagandha is out. Hyperthyroidism, Graves' disease and thyroid hormone therapy are all on its contraindication list, Sharma 2018 shows it moves TSH, T3 and T4, and our report carries a 2024 case of painless thyroiditis after use. That is a mechanism working as designed in the wrong person.
Anyone with liver disease, current or past
Shilajit
Ashwagandha is out again, and this one is not a theoretical risk. LiverTox 2024 lists it as a likely cause of clinically apparent liver injury, and Bjornsson 2020 documents five cases with a mixed or cholestatic pattern and prolonged jaundice. Shilajit's downside is contamination, which you can test your way out of.
Pregnant, breastfeeding, or trying to conceive
Tie
Neither. Pregnancy and breastfeeding are on both contraindication lists. LactMed 2024 reports no valid safety or efficacy data for ashwagandha in nursing mothers or infants, and shilajit adds a heavy-metal exposure route that matters more in this population than any other.
Trained lifter chasing strength and recovery
Tie
Strength and power runs 6.0 shilajit against 5.0 ashwagandha, but ashwagandha holds the resistance-training RCT (Wankhede 2015) and the performance meta-analysis (Bonilla 2021). Neither is a large effect. This is a row where training and protein decide the outcome and the supplement is a rounding error.
Research Highlights
-
Mechanism Difference
Shilajit and ashwagandha are complementary, not interchangeable. Shilajit is a fulvic and humic acid matrix that chelates trace minerals and dibenzo-alpha-pyrones into small complexes; its human signals come from mineral transport, antioxidant activity and mild gonadotropic signaling.Ashwagandha is a withanolide-rich root extract that damps HPA-axis output and lowers cortisol while modulating GABA-A signaling, with secondary thyroid and androgen effects. The two share no named pathway, which is why shilajit scores 6.5 on energy and 2.5 on anxiety while ashwagandha scores 3.5 and 7.5 on the same two.
-
Safety Comparison
Ashwagandha carries the more serious documented harms. LiverTox 2024 lists it as a likely cause of clinically apparent liver injury, Bjornsson 2020 documents five cases with prolonged jaundice, and it is contraindicated in hyperthyroidism, Graves' disease and thyroid hormone therapy because Sharma 2018 shows it actually moves TSH, T3 and T4.Shilajit's risk is contamination rather than pharmacology. Unpurified resin is the heavy-metal exposure route the FDA's Ayurvedic advisory describes, which is why its access field requires lot-specific testing. That is a manageable risk if you buy correctly and an unmanaged one if you do not.
-
Cost Comparison
Ashwagandha runs about $15 to $30 a month for third-party-tested KSM-66 at 600 mg/day. Purified shilajit runs $25 to $50 a month at 300 to 500 mg/day. Both are retail estimates priced in September 2026, not measured prices.Duration matters more than the $15 gap. Ashwagandha's own contraindication list names continuous use beyond 8 to 12 weeks without a break, so its real annual cost is a fraction of twelve months. Shilajit has a 12-week assessment window and no built-in washout, so budget the full year.
-
Editorial Verdict
Shilajit scores 7.4 and ashwagandha 6.8, and the gap is a downside gap rather than an effect gap. The decision is made by your complaint, not by the overall number. Take shilajit for hormonal, fertility, energy and bone outcomes, where its subratings run 6.5 to 7.5.Take ashwagandha for stress, anxiety, sleep and mood, where it runs 6.0 to 7.5 and shilajit runs 2.0 to 4.0. Ashwagandha has by far the deeper evidence base, six systematic reviews and meta-analyses against a handful of small ingredient-funded trials, so its lower score reflects its risk profile rather than any doubt about whether it works.
-
Durability
Neither holds a durability advantage. Both score 2.5 out of 5.0 on durability, meaning the benefit tracks the dose and fades when you stop. Nothing on either report tests what happens six months after cessation.Their time courses differ, though, and that changes how you evaluate them. Ashwagandha shows a first change in about a week and is fully assessed at eight. Shilajit takes about four weeks to first signal and twelve to full effect, so a four-week shilajit trial answers nothing.
Frequently Asked Questions
- Is shilajit better than ashwagandha?
- Only for a specific set of jobs. Shilajit scores 7.4 overall against ashwagandha's 6.8 and wins hormonal (7.5 to 6.5), male fertility (7.5 to 6.0), energy (6.5 to 3.5) and bone (6.5 to 4.0). Ashwagandha wins anxiety (7.5 to 2.5), stress resilience (7.5 to 4.0), sleep quality (6.5 to 2.0) and mood (6.0 to 3.0). Match the product to your complaint rather than to the higher number.
- Can I take shilajit and ashwagandha together?
- Yes, and it is one of the few supplement pairs where stacking has a mechanism story behind it. Shilajit works through trace-mineral transport and antioxidant activity, ashwagandha through HPA-axis damping and GABA-A signaling, so they are complementary rather than redundant. Neither contraindication list names the other. Start them four weeks apart so a null result tells you which one failed.
- Which one works faster?
- Ashwagandha, by about three weeks. It gives a first noticeable change in roughly one week and reaches full effect at eight, which is also its assessment window. Shilajit takes about four weeks to first signal and twelve to full effect. Judging shilajit at four weeks is judging it before the trial data says anything should have happened.
- Which one is safer?
- Shilajit, on documented harm, provided you buy tested product. Ashwagandha's downside total is 1.258 against shilajit's 0.783, driven by real liver-injury cases (LiverTox 2024, Bjornsson 2020) and thyroid stimulation that rules it out in hyperthyroidism or on levothyroxine. Shilajit's risk is heavy-metal contamination in unpurified product, which lot-specific testing removes.
- Does shilajit actually raise testosterone?
- The evidence points that way and it is thin. Pandit 2016 is a small randomized trial reporting increased total testosterone, free testosterone and DHEAS after 500 mg/day for 90 days, and it was funded by the ingredient manufacturer. The Endocrine Society testosterone guideline contains no shilajit recommendation. Treat it as a plausible modest effect, not a TRT alternative.
- Do I need to cycle ashwagandha?
- Its own contraindication list names continuous use beyond 8 to 12 weeks without a break, so plan the break before you start. That is also why the annual cost comparison favors it more than the monthly one does. Shilajit has no equivalent built-in washout, though its 12-week assessment window is a natural point to decide whether to continue.
- Which should I avoid entirely?
- Avoid ashwagandha with any thyroid condition, thyroid hormone therapy, current or past liver disease, sedatives or immunosuppressants. Avoid shilajit with hemochromatosis or iron overload, bleeding disorders, surgery inside two weeks, or any product without a lot-specific heavy-metal test. Avoid both in pregnancy, breastfeeding and pediatric use.
- Will either one help me sleep?
- Ashwagandha will, modestly. Its sleep quality subrating is 6.5 and sleep architecture 4.5, and Langade 2019 measured both objective and subjective sleep in an insomnia and anxiety population. Shilajit scores 2.0 and 1.0 on the same two, and circadian rhythm 1.0. There is no mechanism there. Do not buy shilajit expecting sleep.
Evidence Sources
- RCT Clinical evaluation of purified shilajit on testosterone levels in healthy volunteers (2016) Small RCT reporting increased total testosterone, free testosterone and DHEAS after 500 mg/day for 90 days.
- RCT Clinical evaluation of spermatogenic activity of processed shilajit in oligospermia (2010) Improved sperm parameters with testosterone and FSH moving in the expected direction in oligospermic men.
- RCT Effects of shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels (2019) RCT in 63 recreationally active men. High-dose shilajit better preserved fatigue-related strength.
- RCT Effects of 8 weeks of shilajit supplementation on serum pro-c1alpha1 (2022) RCT in 35 recreationally trained men. 500 and 1000 mg/day increased a type 1 collagen synthesis marker.
- RCT Shilajit extract reduces oxidative stress, inflammation, and bone loss (2022) RCT in 60 osteopenic postmenopausal women over 48 weeks. Dose-dependent preservation of lumbar-spine and femoral-neck BMD.
- Review Shilajit: a natural phytocomplex with potential procognitive activity (2012) Mechanistic review on fulvic acid, tau aggregation and cognitive-aging relevance.
- Regulatory Lead, chromium, and arsenic in some traditional Ayurvedic medicines (2026) Regulatory risk context for contaminated Ayurvedic products and heavy-metal exposure.
- Guideline AUA/ASRM diagnosis and treatment of infertility in men: guideline (2026) The relevant male infertility authority contains no shilajit recommendation.
- Meta-analysis Safety and efficacy of Withania somnifera for anxiety and insomnia: systematic review and meta-analysis (2024) 5 RCTs, n=254. Reduced HAM-A anxiety scores and improved several sleep parameters, with high heterogeneity.
- Meta-analysis Effects of Ashwagandha on stress and anxiety: systematic review and meta-analysis (2024) 9 RCTs, n=558. Reduced perceived stress, anxiety and serum cortisol versus placebo.
- Meta-analysis Effects of Ashwagandha on mental health in adults: systematic review and dose-response meta-analysis (2026) 22 RCTs, n=1391. Improvements in stress, anxiety and depression, with dose and duration effects and low-certainty limitations.
- RCT Ashwagandha root extract in insomnia and anxiety: randomized placebo-controlled study (2019) Sleep and anxiety RCT with both objective and subjective sleep outcomes.
- Meta-analysis Effect of Ashwagandha extract on sleep: systematic review and meta-analysis (2021) Small significant overall sleep effect, stronger in insomnia, at higher doses and over longer durations.
- RCT Withania somnifera supplementation on muscle strength and recovery: randomized controlled trial (2015) Resistance-training RCT supporting strength, recovery and training-adaptation benefits.
- Meta-analysis Effects of Ashwagandha on physical performance: systematic review and Bayesian meta-analysis (2021) Bayesian meta-analysis supporting physical-performance benefits.
- RCT Ashwagandha root extract in subclinical hypothyroid patients (2018) Double-blind RCT supporting TSH, T3 and T4 normalization. The same mechanism is why hyperthyroidism is a contraindication.
- Case series Ashwagandha as a cause for liver injury (2020) Five liver-injury cases with a mixed or cholestatic pattern and prolonged jaundice, resolving in the reported cases.
- Monograph LiverTox: Ashwagandha, NCBI Bookshelf (2024) NIH hepatotoxicity monograph listing ashwagandha as a likely cause of clinically apparent liver injury.
- Monograph Withania, LactMed, NCBI Bookshelf (2024) No valid safety or efficacy data for nursing mothers or infants.
- Systematic review Biopsychological effects of Ashwagandha in athletes and healthy individuals: systematic review (2025) Overview of 11 systematic reviews, 151 original studies, n=9005. Signals for endurance, strength, anxiety, sleep and sexual function, with explicit caution on evidence limits.
Glossary
Quick reference for the medical and technical terms used in this comparison.
- HPA axis Hypothalamic-Pituitary-Adrenal Axis
- The hormone loop that runs your stress response and ends in cortisol release. Ashwagandha damps it. Shilajit does not touch it.
- DHEAS Dehydroepiandrosterone Sulfate
- An adrenal androgen precursor, and one of the hormones Pandit 2016 reported rising on shilajit alongside total and free testosterone.
- HAM-A Hamilton Anxiety Rating Scale
- The standard clinician-rated anxiety questionnaire. It is the endpoint Fatima 2024 pooled across five ashwagandha RCTs.
- BMD Bone Mineral Density
- The DEXA measurement used to diagnose osteopenia and osteoporosis. Pingali 2022 tracked it at the lumbar spine and femoral neck over 48 weeks on shilajit.
- KSM-66 KSM-66 Ashwagandha
- A standardized root-only withanolide extract. It is the branded material used in most ashwagandha trials cited here, and the reason the extract costs more than raw powder.
- GABA-A Gamma-Aminobutyric Acid Type A Receptor
- The main inhibitory receptor in the brain, the same one benzodiazepines act on. Ashwagandha modulates it, which is why sedatives are on its interaction list.
- Fulvic acid Fulvic Acid
- The low-molecular-weight fraction of humic substances in shilajit. It is the carrier that chelates trace minerals and dibenzo-alpha-pyrones into absorbable complexes.
- TSH Thyroid Stimulating Hormone
- The pituitary signal that drives thyroid output. Sharma 2018 showed ashwagandha normalizes it in subclinical hypothyroidism, which is also why it is unsafe in overactive thyroid.
